Top Shares To Buy At Low Prices For Good Returns

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Markets have cracked a bit and the Nifty is down almost 7 per cent from peak levels. However, the damage in broader markets has been enormous. Here are a few stocks that have fallen dramatically and some are at 52-week lows. Let us see if you should take the risk to buy them.

    Jagran Prakashan

    Jagran Prakashan

    Jagran Prakashan owns Dainik Jagran, which is the number one read daily in the country. This is a stock to buy for a number of reasons. The first is that the stock is trading at Rs 165, which is very close to its 52-week low of Rs 160. The second is that with elections around the corner in some big states like Madhya Pradesh and Rajasthan, the company could see tremendous traction in revenues.

    With country wide elections for the central government slated next year, we should see even more momentum in the share price.

    Now there are a number of other reasons to be buying the stock as well. The revenues from the Non Print Businesses has been growing rapidly and constituted 20 per cent in the first nine months of FY18. The radio business has delivered 30 per cent EBITDA Margins for 3 consecutive quarters and Digital Advertisement Business has shown a growth in revenue of 23 per cent, year to date.

    Solid financials

    Solid financials

    Dainik Jagran leads the IRS 2017 rankings with a total readership of 7 crores. In places like UP, NCR etc., it continues be the number one read daily. Jagran also owns Mumbai's popular evening read newspaper "mid-day" and "Nai Duniya".

    The company reported solid financials for the quarter ending Dec 31, 2017. The EPS of the company surged to Rs 2.49 from Rs 1.98 in the previous quarter.

    For 2018-19, we believe the company is on track to do an EPS of Rs 12 at the very least. If you apply a p/e of 20 times, the stock should trade at Rs 240 at the very least. Jagran Shares are a good pick at the current price of Rs 165. Check stock quote of Jagran here

    Punjab National Bank

    Punjab National Bank

    This stock dipped after reports of fraud at the bank in which it is likely that PNB could face damages of Rs 11,000 crores. The case involves select PNB employees, who acted in connivance with a private company owned by Nirav Modi to issue letter of undertakings or guarantees that allowed Nirav Modi's firms access to money from other banks.

    Never mind the case, as things stand PNB is taking a hit of a staggering Rs 11,000 crores. And, with the bank already saddled with bad bets the repercussions could be disastrous. However, there are clarifications from the bank that Nirav Modi has agreed to make good the amount.

    Is it worth buying PNB now?

    Is it worth buying PNB now?

    It is often noticed that after such major developments, there is a crack in the stock. PNB shares have fallen to a new 52-week low of Rs 94.

    In fact, in two-weeks the stock has fallen from levels of Rs 161 to Rs 94. At these levels the stock has the potential to bounce back. Over a period of three to six months everything tends to be forgotten and things are back to usual.

    From that perspective it should be remembered that PNB may give decent returns. Coming to fundamentals, if the bank has to take the complete hit of Rs 11,000 crores, it is going to be a big damage. So it really depends if Nirav Modi coughs-up the entire amount or else the bad debts are going to worsen. In the more short term period of three to six months, the stock has the potential to generate returns.

    Check stock quote of PNB here

    Glenmark Pharma

    Glenmark Pharma

    This is another stock that has slumped to a new 52-week low. For the third quarter ended December 31, 2017, Glenmark's reported sales was at Rs. 2203 crores, as against Rs. 2535 crores, showing a drop of 13.07 per cent.

    The Net Profit was at Rs. 104.7 crores or the quarter ended December 31, 2017 as compared to Rs. 477 crores for the previous corresponding quarter.

    Clearly, the results of the pharma major was below expectations. This has resulted in a slump in the stock price and even at these 52-week low levels, the stock looks a lot expensive. It is best to avoid the stock at the current levels.

    Read more about: stocks jagran prakashan
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more